Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2004305069 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Arrington, Kenneth L.; Hartman, George D.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2004305069

PCT Pub. Number WO2005/060654

Priority 60/531,554 19.12.03 US

Filing date 15 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 25 February 2010

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

C07D 239/36 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/060654 Priority application(s): WO2005/060654

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

25 February 2010 Application Accepted

  Published as AU-B-2004305069

8 April 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Mar 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

29 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Mar 2010

5 August 2010 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305075-Methods and materiale for assessing prostate cancer therapies

2004305066-Monitoring method and apparatus